Management of acute and cutaneous porphyrias

International Journal of Clinical Practice

Volumn 56, Issue 4, 2002, Pages 272-278

  Badminton, M N ^a   Elder, G H ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIEMETIC AGENT; ATENOLOL; BETA CAROTENE; CHLOROQUINE; CHLORPROMAZINE; CLONAZEPAM; CYCLIZINE; DIAMORPHINE; DIAZEPAM; DIHYDROCODEINE; ELECTROLYTE; GLUCOSE; HEMATIN; HEME; HEME ARGINATE; LABETALOL; LAXATIVE; MAGNESIUM SULFATE; MORPHINE; OPIATE; PARACETAMOL; PETHIDINE; PHENOTHIAZINE; PORPHYRIN; PROMAZINE; PROPRANOLOL; SODIUM CHLORIDE; SUNSCREEN; UNINDEXED DRUG;

ABDOMINAL PAIN; ACUTE DISEASE; ALCOHOL CONSUMPTION; ANALGESIA; BLISTER; BONE MARROW TRANSPLANTATION; CONFUSION; CONGENITAL ERYTHROPOIETIC PORPHYRIA; DIET; ERYTHROPOIETIC PROTOPORPHYRIA; FOLLOW UP; HUMAN; HYPERTENSION; HYPONATREMIA; LIFESTYLE; PATIENT COUNSELING; PHLEBOTOMY; PHOTOSENSITIVITY; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; RELATIVE; REVIEW; RISK ASSESSMENT; SEIZURE; SKIN DEFECT; SMOKING CESSATION; SUNLIGHT; SYMPTOM; THROMBOPHLEBITIS; URINARY EXCRETION;

ARGININE; BETA CAROTENE; CHLOROQUINE; ESTROGENS; ETHANOL; HEME; HUMANS; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PORPHYRIA, ACUTE INTERMITTENT; PORPHYRIAS; SUNLIGHT;

EID: 0036279280     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias
2. Hepatic porphyrias in children
3. Front line tests for the investigation of suspected porphyria
4. Diagnosis and management of porphyria
5. Genetic defects in the porphyrias: Types and significance
6. The biochemistry of heme synthesis in porphyria and in the porphyrinurias
7. A R59W mutation in human protoporphyrinogen oxidase results in decreased activity and is prevalent in South Africans with variegate porphyria
8. Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria
9. Hereditary coproporphyria
10. Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria
11. Acute intermittent porphyria: Prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France
12. The acute porphyrias
13. Treatment of acute porphyria
14. Acute intermittent porphyria and mental illness: A family study
15. Drug treatment in acute porphyria
16. Management of acute attacks in the porphyrias
17. Early administration of heme arginate for acute porphyric attacks
18. The treatment of acute intermittent porphyria with laevulose
19. A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria
20. Porphyrias
21. Acute porphyrias
22. The cutaneous porphyrias: A review
23. The cutaneous porphyrias
24. Treatment of the cutaneous porphyrias
25. Porphyria cutanea tarda
26. Porphyria cutanea tarda
27. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda
28. Hepatocellular carcinoma in porphyria cutanea tarda: Frequency and factors related to its occurrence
29. The management of porphyria cutanea tarda
30. Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection
31. Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: A case report and review of the literature
32. Variegate porphyria in Western Europe: Identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation
33. Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria
34. Erythropoietic protoporphyria
35. Inheritance in erythropoietic protoporphyria: A common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation
36. Erythropoietic protoporphyria: An overview with emphasis on the liver
37. Liver failure in protoporphyria: Long-term treatment with oral charcoal